• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童药物清除率的预测:体表面积指数、体重和年龄的影响。

Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.

作者信息

Mahmood Iftekhar

机构信息

From the Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food & Drug Administration, Bethesda, Maryland, USA.

出版信息

Ther Drug Monit. 2007 Jun;29(3):271-8. doi: 10.1097/FTD.0b013e318042d3c4.

DOI:10.1097/FTD.0b013e318042d3c4
PMID:17529882
Abstract

In recent years, with the advent of pediatric exclusivity and requirements for conducting clinical studies involving children, emphasis has been placed on finding safe and efficacious doses of drugs for children. It has been suggested that one can predict the clearance (CL) of a drug in children according to this equation: CL in the child = Adult CL * (Weight of the child/70)0.75. In light of the controversy surrounding the exponent of 0.75 for the prediction of clearance, the objectives of the study were as follows: (1) to develop allometric equations based on body weight or age to predict clearance of a drug in children; (2) to determine if the fixed exponent of 0.75 is a suitable exponent for the prediction of clearance in children from adult data, as compared with the allometric exponent generated for individual drugs; (3) to determine if the allometric equation generated on the basis of age predicts clearance in children better or worse than the allometric equation generated on the basis of body weight; and (4) to propose a new approach based on the findings of the current evaluation. Five methods were used to predict drug clearance in children. Six drugs were used in the evaluation, and drug clearance in each child was predicted for a given drug. Besides evaluating the exponent of 0.75, allometric equations were developed using double log plots of clearance versus body weight or age. The exponents of the allometric equations were then used to predict drug clearance by replacement of 0.75 in the aforementioned equation. The results of the study indicate that 0.75 is not the best exponent for prediction of drug clearance in children, and a more suitable approach is to develop an allometric relationship for a given drug in children. For all 6 drugs, there were 77 children in whom the clearance was predicted. There were 48 observations for which error in the predicted clearance was 50% or more with use of the exponent 0.75, whereas there were only 13 observations with prediction error > or = 50% when 0.75 was replaced by an allometric exponent developed for a given drug. In order to predict drug clearance in children with reasonable accuracy, an allometric equation should be developed for every drug and the exponent 0.75 should be replaced by the exponent of the allometric equation developed for that drug.

摘要

近年来,随着儿科药物独占期的出现以及开展涉及儿童的临床研究的要求,人们开始着重寻找儿童用药的安全有效剂量。有人提出,可以根据以下公式预测儿童药物清除率(CL):儿童CL = 成人CL×(儿童体重/70)^0.75。鉴于围绕预测清除率时指数0.75存在的争议,本研究的目的如下:(1)基于体重或年龄建立异速生长方程,以预测儿童药物清除率;(2)与针对个别药物生成的异速生长指数相比,确定固定指数0.75是否适合根据成人数据预测儿童清除率;(3)确定基于年龄生成的异速生长方程预测儿童清除率的效果优于还是差于基于体重生成的异速生长方程;(4)根据当前评估结果提出一种新方法。采用了五种方法预测儿童药物清除率。评估中使用了六种药物,并针对每种药物预测每个儿童的药物清除率。除了评估指数0.75外,还通过清除率与体重或年龄的双对数图建立了异速生长方程。然后,将异速生长方程的指数代入上述公式中替换0.75,以预测药物清除率。研究结果表明,0.75并非预测儿童药物清除率的最佳指数,更合适的方法是针对儿童特定药物建立异速生长关系。对于所有6种药物,共对77名儿童的清除率进行了预测。使用指数0.75时,有48次预测清除率的误差达到或超过50%,而当用针对特定药物生成的异速生长指数替换0.75时,只有13次预测误差≥50%。为了合理准确地预测儿童药物清除率,应为每种药物建立异速生长方程,并将指数0.75替换为针对该药物建立的异速生长方程的指数。

相似文献

1
Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.儿童药物清除率的预测:体表面积指数、体重和年龄的影响。
Ther Drug Monit. 2007 Jun;29(3):271-8. doi: 10.1097/FTD.0b013e318042d3c4.
2
Prediction of drug clearance in children from adults: a comparison of several allometric methods.从成人预测儿童的药物清除率:几种异速生长方法的比较。
Br J Clin Pharmacol. 2006 May;61(5):545-57. doi: 10.1111/j.1365-2125.2006.02622.x.
3
Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model.从大鼠、儿童和成人建立的体表面积比例模型预测丙泊酚清除率与 0.75 固定指数体表面积比例模型的比较。
Clin Pharmacokinet. 2010 Apr;49(4):269-75. doi: 10.2165/11319350-000000000-00000.
4
Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.早产儿、足月儿及2岁以下婴幼儿药物清除率的预测:4种异速生长模型预测性能的比较
J Clin Pharmacol. 2016 Jun;56(6):733-9. doi: 10.1002/jcph.652. Epub 2015 Dec 21.
5
Prediction of drug clearance in children 3 months and younger: an allometric approach.3个月及以下儿童药物清除率的预测:一种异速生长方法。
Drug Metabol Drug Interact. 2010;25(1-4):25-34. doi: 10.1515/DMDI.2010.004.
6
Application of fixed exponent 0.75 to the prediction of human drug clearance: an inaccurate and misleading concept.将固定指数0.75应用于人体药物清除率预测:一个不准确且具有误导性的概念。
Drug Metabol Drug Interact. 2009;24(1):57-81. doi: 10.1515/dmdi.2009.24.1.57.
7
Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.极低出生体重至低出生体重新生儿药物清除率、分布容积和半衰期的预测:一种异速生长法
Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):601-610. doi: 10.1007/s13318-016-0372-z.
8
Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults.用于从新生儿到成人按比例调整茶碱清除率和维持剂量的年龄和体重依赖性异速生长指数模型。
Ther Drug Monit. 2018 Oct;40(5):635-641. doi: 10.1097/FTD.0000000000000543.
9
Prediction of drug clearance in children: an evaluation of the predictive performance of several models.儿童药物清除率的预测:几种模型预测性能的评估。
AAPS J. 2014 Nov;16(6):1334-43. doi: 10.1208/s12248-014-9667-7. Epub 2014 Oct 2.
10
A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.从新生儿到青少年的药物清除预测的比较研究:比例缩放与基于生理学的药代动力学建模。
J Clin Pharmacol. 2019 Feb;59(2):189-197. doi: 10.1002/jcph.1310. Epub 2018 Sep 7.

引用本文的文献

1
Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects.使自主神经系统脱敏以减轻抗GD2单克隆抗体的副作用。
Front Oncol. 2024 May 15;14:1380917. doi: 10.3389/fonc.2024.1380917. eCollection 2024.
2
Performance of the allometric power model in scaling from adult to paediatric antiretroviral dose in children at a Referral Hospital in Windhoek, Namibia.在纳米比亚温得和克的一家转诊医院,从成人到儿科抗逆转录病毒剂量的比例幂模型在儿童中的表现。
Afr Health Sci. 2022 Sep;22(3):436-441. doi: 10.4314/ahs.v22i3.47.
3
The willingness of parents to vaccinate their children younger than 12 years against COVID-19: a cross-sectional study in Malaysia.
家长愿意为 12 岁以下儿童接种 COVID-19 疫苗:马来西亚的一项横断面研究。
BMC Public Health. 2022 Jun 29;22(1):1265. doi: 10.1186/s12889-022-13682-z.
4
Amikacin Therapy in Japanese Pediatric Patients: Narrative Review.阿米卡星治疗日本儿科患者:叙事性综述。
Int J Environ Res Public Health. 2022 Feb 10;19(4):1972. doi: 10.3390/ijerph19041972.
5
Obesity and anesthetic pharmacology: simulation of target-controlled infusion models of propofol and remifentanil.肥胖与麻醉药理学:丙泊酚和瑞芬太尼靶控输注模型的模拟。
Korean J Anesthesiol. 2021 Dec;74(6):478-487. doi: 10.4097/kja.21345. Epub 2021 Aug 18.
6
How to Treat Sepsis in the Background of Resistance?: Role of Pharmacodynamics / Pharmacokinetics in Treating Sepsis.如何在耐药背景下治疗脓毒症?:药效动力学/药代动力学在脓毒症治疗中的作用。
Indian J Pediatr. 2020 Feb;87(2):111-116. doi: 10.1007/s12098-019-03153-6. Epub 2020 Jan 14.
7
Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults.从儿童(>2 岁)和成人数据中使用经验模型推断≤2 岁儿童的药物清除率。
Drugs R D. 2020 Mar;20(1):1-10. doi: 10.1007/s40268-019-00291-2.
8
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival.抗GD2单克隆抗体hu3F8联合GM-CSF的I期试验:体重、免疫原性和抗GD2反应对药代动力学和生存的影响。
Oncoimmunology. 2017 Jul 31;6(11):e1358331. doi: 10.1080/2162402X.2017.1358331. eCollection 2017.
9
Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.小儿肾移植受者的他克莫司剂量需求具有双相过程的特点,该过程由年龄和骨骼成熟度决定。
Br J Clin Pharmacol. 2017 Apr;83(4):863-874. doi: 10.1111/bcp.13174. Epub 2016 Dec 13.
10
Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants.表征新生儿和婴儿中西罗莫司清除率的发育轨迹。
CPT Pharmacometrics Syst Pharmacol. 2016 Aug;5(8):411-7. doi: 10.1002/psp4.12096. Epub 2016 Aug 8.